🇺🇸 FDA
Patent

US 9808543

Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

granted A61KA61K2300/00A61K31/555

Quick answer

US patent 9808543 (Iron garnet nanoparticles for cancer radiotherapy and chemotherapy) held by The Board of Regents of the University of Texas System expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2300/00, A61K31/555, A61K33/00, A61K33/22